Cargando…
Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer
Non-small cell lung cancer is the predominant type of lung cancer, resulting in high mortality worldwide. Digoxin, a cardiac glycoside, has recently been suggested to be a novel chemotherapeutic agent. Src is an oncogene that plays an important role in cancer progression and is therefore a potential...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425490/ https://www.ncbi.nlm.nih.gov/pubmed/25955608 http://dx.doi.org/10.1371/journal.pone.0123305 |
_version_ | 1782370489716441088 |
---|---|
author | Lin, Sheng-Yi Chang, Hsiu-Hui Lai, Yi-Hua Lin, Ching-Hsiung Chen, Min-Hsuan Chang, Gee-Chen Tsai, Meng-Feng Chen, Jeremy J. W. |
author_facet | Lin, Sheng-Yi Chang, Hsiu-Hui Lai, Yi-Hua Lin, Ching-Hsiung Chen, Min-Hsuan Chang, Gee-Chen Tsai, Meng-Feng Chen, Jeremy J. W. |
author_sort | Lin, Sheng-Yi |
collection | PubMed |
description | Non-small cell lung cancer is the predominant type of lung cancer, resulting in high mortality worldwide. Digoxin, a cardiac glycoside, has recently been suggested to be a novel chemotherapeutic agent. Src is an oncogene that plays an important role in cancer progression and is therefore a potential target for cancer therapy. Here, we investigated whether digoxin could suppress lung cancer progression through the inhibition of Src activity. The effects of digoxin on lung cancer cell functions were investigated using colony formation, migration and invasion assays. Western blotting and qPCR assays were used to analyze the mRNA and protein expression levels of Src and its downstream proteins, and a cell viability assay was used to measure cellular cytotoxicity effects. The results of the cell function assays revealed that digoxin inhibited the proliferation, invasion, migration, and colony formation of A549 lung cancer cells. Similar effects of digoxin were also observed in other lung cancer cell lines. Furthermore, we found that digoxin significantly suppressed Src activity and its protein expression in a dose- and time-dependent manner as well as reduced EGFR and STAT3 activity. Our data suggest that digoxin is a potential anticancer agent that may suppress lung cancer progression through inhibiting Src and the activity of related proteins. |
format | Online Article Text |
id | pubmed-4425490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44254902015-05-21 Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer Lin, Sheng-Yi Chang, Hsiu-Hui Lai, Yi-Hua Lin, Ching-Hsiung Chen, Min-Hsuan Chang, Gee-Chen Tsai, Meng-Feng Chen, Jeremy J. W. PLoS One Research Article Non-small cell lung cancer is the predominant type of lung cancer, resulting in high mortality worldwide. Digoxin, a cardiac glycoside, has recently been suggested to be a novel chemotherapeutic agent. Src is an oncogene that plays an important role in cancer progression and is therefore a potential target for cancer therapy. Here, we investigated whether digoxin could suppress lung cancer progression through the inhibition of Src activity. The effects of digoxin on lung cancer cell functions were investigated using colony formation, migration and invasion assays. Western blotting and qPCR assays were used to analyze the mRNA and protein expression levels of Src and its downstream proteins, and a cell viability assay was used to measure cellular cytotoxicity effects. The results of the cell function assays revealed that digoxin inhibited the proliferation, invasion, migration, and colony formation of A549 lung cancer cells. Similar effects of digoxin were also observed in other lung cancer cell lines. Furthermore, we found that digoxin significantly suppressed Src activity and its protein expression in a dose- and time-dependent manner as well as reduced EGFR and STAT3 activity. Our data suggest that digoxin is a potential anticancer agent that may suppress lung cancer progression through inhibiting Src and the activity of related proteins. Public Library of Science 2015-05-08 /pmc/articles/PMC4425490/ /pubmed/25955608 http://dx.doi.org/10.1371/journal.pone.0123305 Text en © 2015 Lin et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lin, Sheng-Yi Chang, Hsiu-Hui Lai, Yi-Hua Lin, Ching-Hsiung Chen, Min-Hsuan Chang, Gee-Chen Tsai, Meng-Feng Chen, Jeremy J. W. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer |
title | Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer |
title_full | Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer |
title_fullStr | Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer |
title_full_unstemmed | Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer |
title_short | Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer |
title_sort | digoxin suppresses tumor malignancy through inhibiting multiple src-related signaling pathways in non-small cell lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425490/ https://www.ncbi.nlm.nih.gov/pubmed/25955608 http://dx.doi.org/10.1371/journal.pone.0123305 |
work_keys_str_mv | AT linshengyi digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT changhsiuhui digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT laiyihua digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT linchinghsiung digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT chenminhsuan digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT changgeechen digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT tsaimengfeng digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer AT chenjeremyjw digoxinsuppressestumormalignancythroughinhibitingmultiplesrcrelatedsignalingpathwaysinnonsmallcelllungcancer |